NeuroSense Therapeutics Ltd. Form 20-F: Annual report of foreign private issuer
Filings on SEC EDGAR, newest first; amendments sit with their base form. Values are as filed.
- 2026-03-31: Form 20-F; Period of report 2025-12-31; Description ANNUAL REPORT; Document ea0283072-20f_neurosense.htm.
- 2025-04-07: Form 20-F; Period of report 2024-12-31; Description ANNUAL REPORT; Document ea0237295-20f_neuro.htm.
- 2024-04-04: Form 20-F; Period of report 2023-12-31; Description ANNUAL REPORT; Document ea0202964-20f_neuro.htm.
- 2023-03-22: Form 20-F; Period of report 2022-12-31; Description ANNUAL REPORT; Document f20f2022_neurosense.htm.
| Filed | Form | Period of report | Description | Document |
|---|---|---|---|---|
| 2026-03-31 | 20-F | 2025-12-31 | ANNUAL REPORT | ea0283072-20f_neurosense.htm |
| 2025-04-07 | 20-F | 2024-12-31 | ANNUAL REPORT | ea0237295-20f_neuro.htm |
| 2024-04-04 | 20-F | 2023-12-31 | ANNUAL REPORT | ea0202964-20f_neuro.htm |
| 2023-03-22 | 20-F | 2022-12-31 | ANNUAL REPORT | f20f2022_neurosense.htm |
| 2022-04-14 | 20-F | 2021-12-31 | ANNUAL REPORT | f20f2021_neurosense.htm |